Sweden's ChemoTech Q4 sales rise on Animal Care unit strength

Reuters

Feb 17

Sweden's ChemoTech Q4 sales rise on Animal Care unit strength

Overview

Swedish medical tech firm's Q4 net sales rose yr/yr, driven by Animal Care segment
Q4 operating cash flow improved significantly compared to last year
Company reports strong Animal Care sales and first U.S. order from equine clinic

Outlook

ChemoTech plans initial technical tests for next-gen vetIQure platform in 2026
Company sees North America as key market opportunity for growth
ChemoTech aims to strengthen presence in Europe as market conditions evolve

Result Drivers

ANIMAL CARE SALES - Strong Q4 sales in Animal Care segment exceeded expectations despite anticipated seasonal slowdown
U.S. MARKET ENTRY - First U.S. order from leading equine clinic in Kentucky marks significant market entry
TREATMENT KIT SALES - Cumulative number of treatment kits sold more than doubled from 2024, driven by higher utilization and confidence

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Sales		SEK 2.65 mln
Q4 EPS		-SEK 0.10
Q4 Operating Cash Flow		-SEK 338,000

Analyst Coverage

Wall Street's median 12-month price target for Scandinavian ChemoTech AB is SEK6.30, about 67.6% above its February 16 closing price of SEK3.76

Press Release: ID:nWkr1q9DYr

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2612443036"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612443036\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612443036?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-17 15:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612443036","market":"fut","top_or_hot":-1,"title":"Sweden's ChemoTech Q4 sales rise on Animal Care unit strength","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sweden's ChemoTech Q4 sales rise on Animal Care unit strength</title></head><body><p><span>Overview</span></p><ul><li><p>Swedish medical tech firm's Q4 net sales rose yr/yr, driven by Animal Care segment</p></li><li><p>Q4 operating cash flow improved significantly compared to last year</p></li><li><p>Company reports strong Animal Care sales and first U.S. order from equine clinic</p></li></ul><p><span>Outlook</span></p><ul><li><p>ChemoTech plans initial technical tests for next-gen vetIQure platform in 2026</p></li><li><p>Company sees North America as key market opportunity for growth</p></li><li><p>ChemoTech aims to strengthen presence in Europe as market conditions evolve</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ANIMAL CARE SALES - Strong Q4 sales in Animal Care segment exceeded expectations despite anticipated seasonal slowdown</p></li><li><p>U.S. MARKET ENTRY - First U.S. order from leading equine clinic in Kentucky marks significant market entry</p></li><li><p>TREATMENT KIT SALES - Cumulative number of treatment kits sold more than doubled from 2024, driven by higher utilization and confidence</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>SEK 2.65 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-SEK 0.10</p></td><td></td></tr><tr><td><p>Q4 Operating Cash Flow</p></td><td></td><td><p>-SEK 338,000</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for Scandinavian ChemoTech AB is SEK6.30, about 67.6% above its February 16 closing price of SEK3.76</p></li></ul><p>Press Release: <span>ID:nWkr1q9DYr</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sweden's ChemoTech Q4 sales rise on Animal Care unit strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSweden's ChemoTech Q4 sales rise on Animal Care unit strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-17 15:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sweden's ChemoTech Q4 sales rise on Animal Care unit strength</title></head><body><p><span>Overview</span></p><ul><li><p>Swedish medical tech firm's Q4 net sales rose yr/yr, driven by Animal Care segment</p></li><li><p>Q4 operating cash flow improved significantly compared to last year</p></li><li><p>Company reports strong Animal Care sales and first U.S. order from equine clinic</p></li></ul><p><span>Outlook</span></p><ul><li><p>ChemoTech plans initial technical tests for next-gen vetIQure platform in 2026</p></li><li><p>Company sees North America as key market opportunity for growth</p></li><li><p>ChemoTech aims to strengthen presence in Europe as market conditions evolve</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ANIMAL CARE SALES - Strong Q4 sales in Animal Care segment exceeded expectations despite anticipated seasonal slowdown</p></li><li><p>U.S. MARKET ENTRY - First U.S. order from leading equine clinic in Kentucky marks significant market entry</p></li><li><p>TREATMENT KIT SALES - Cumulative number of treatment kits sold more than doubled from 2024, driven by higher utilization and confidence</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>SEK 2.65 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-SEK 0.10</p></td><td></td></tr><tr><td><p>Q4 Operating Cash Flow</p></td><td></td><td><p>-SEK 338,000</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for Scandinavian ChemoTech AB is SEK6.30, about 67.6% above its February 16 closing price of SEK3.76</p></li></ul><p>Press Release: <span>ID:nWkr1q9DYr</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4149","symbol_name":"建筑机械与重型卡车","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nL1N3ZD06F:1","article_id":"2612443036","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612443036","pubTimestamp":1771313964,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sweden's ChemoTech Q4 sales rise on Animal Care unit strengthOverviewSwedish medical tech firm's Q4 net sales rose yr/yr, driven by Animal Care segmentQ4 operating cash flow improved significantly com","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4149":"建筑机械与重型卡车","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","CMI":"康明斯","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC","BK4588":"碎股"},"translate_title":"瑞典ChemoTech第四季度销售额因动物护理部门实力而增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMI":0.9},"content_text":"Sweden's ChemoTech Q4 sales rise on Animal Care unit strengthOverviewSwedish medical tech firm's Q4 net sales rose yr/yr, driven by Animal Care segmentQ4 operating cash flow improved significantly compared to last yearCompany reports strong Animal Care sales and first U.S. order from equine clinicOutlookChemoTech plans initial technical tests for next-gen vetIQure platform in 2026Company sees North America as key market opportunity for growthChemoTech aims to strengthen presence in Europe as market conditions evolveResult DriversANIMAL CARE SALES - Strong Q4 sales in Animal Care segment exceeded expectations despite anticipated seasonal slowdownU.S. MARKET ENTRY - First U.S. order from leading equine clinic in Kentucky marks significant market entryTREATMENT KIT SALES - Cumulative number of treatment kits sold more than doubled from 2024, driven by higher utilization and confidenceKey DetailsMetricBeat/MissActualConsensus EstimateQ4 SalesSEK 2.65 mlnQ4 EPS-SEK 0.10Q4 Operating Cash Flow-SEK 338,000Analyst CoverageWall Street's median 12-month price target for Scandinavian ChemoTech AB is SEK6.30, about 67.6% above its February 16 closing price of SEK3.76Press Release: ID:nWkr1q9DYrFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}